MPWR: the bull case, the bear case, and the verdict
Why the screener flagged it
- Low PEG ratio
- Unusual volume surge
- Revenue growth accelerating
- MACD bullish crossover
- Breakout above 50-day average
The bull case
I need to start here: the bear argument against MPWR fundamentally misunderstands the structural tailwinds driving this company and confuses near-term volatility with long-term value destruction. Let me build the bull case systematically, then address what I believe are flawed bearish assumptions.
Part 1: The undeniable financial reality
Before we debate narratives, let's anchor on what we know from the fundamentals:
The Growth Story Isn't a Story—It's a Math Problem
Q2 2026 Results (Most Recent)
- Revenue: $980.6M (+47.6% YoY)
- Net Income: $257.3M (+90.6% YoY)
- Diluted EPS: $5.51 (+48.5% YoY)
- Operating Margin: 31.0% (up from 24.8% a year ago)
Now, here's what matters: This isn't cherry-picked quarterly noise. We're seeing consistent acceleration over six consecutive quarters:
| Period | Revenue | YoY Growth | Op. Margin |
|---|---|---|---|
| Q2 2026 | $980.6M | +47.6% | 31.0% |
| Q1 2026 | $804.2M | ~+40% est. | 30.0% |
| Q4 2025 | $751.2M | ~+35% est. | 26.6% |
| Q3 2025 | $737.2M | ~+32% est. | 26.5% |
The bull thesis: MPWR is not just growing—it's accelerating, and margins are expanding simultaneously. That's not cyclical optimism; that's structural competitive advantage.
Profitability That Would Make Tech CFOs Jealous
Let me compare MPWR's margin profile to industry peers:
- Gross Margin: 55.2% (exceptional for semiconductors)
- Operating Margin: 31.0% (compare to TXN ~23%, ADI ~18%, ON ~15%)
- ROE (annualized): 27.2% (best-in-class)
Bear argument risk: "Margins are at peak and will compress."
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
The bear case
I appreciate the comprehensive bull argument—it's well-constructed, emotionally compelling, and cleverly uses selective data. But here's what troubles me: the bull is confusing a company in a temporary demand surge with a durable, defensible compounder. MPWR's entire thesis rests on assumptions that are increasingly fragile, and the market is pricing in a perfect scenario that has virtually no margin for error.
Let me be direct: I'm not arguing MPWR is a bad company. I'm arguing it's a dangerous investment at $1,328 because the risk-reward is profoundly asymmetric to the downside.
Part 1: The bull's critical valuation error
Let me start here because this is where the bull argument fundamentally breaks down:
The "Forward P/E" Sleight of Hand
The bull claims MPWR trades at a "reasonable" 35x forward 2027 earnings, with a PEG ratio of 1.89x. This is misleading in ways I need to expose:
What the bull is doing
- Taking Q2 2026 annualized net income (~$1.03B)
- Assuming it grows another 30-40% to reach 2027 EPS of $22-24
- Concluding that $1,328 / $22-24 = 55-60x P/E is "reasonable for high-growth"
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
The research manager's call
Recommendation: Overweight
Rationale: Both sides ran thorough, well-structured arguments, so let me walk through what I found most and least persuasive.
The bull's strongest points were rooted in verifiable near-term data: Q2 2026 revenue of $980.6M growing 47.6% YoY, operating margins expanding to 31% (up from 24.8% a year ago), net income nearly doubling (+90.6% YoY), a fortress balance sheet with $1.4B net cash and essentially zero debt, and Q3 guidance of $1.32–1.39B implying continued acceleration. Critically, inventory days outstanding actually improved from 74 to 69 days despite the revenue surge — that's a sign of operational tightening, not over-ordering. The MACD bullish crossover, RSI at 57 (not overbought), and institutional accumulation on high-volume days all reinforce a near-term technical tailwind. Analyst price targets of $1,700–1,900 imply 28–43% upside from current levels.
The bear made the strongest points on valuation and cycle risk. A 75x current-year P/E is genuinely elevated, and the PEG comparison to NVDA is imperfect — NVDA's moat is deeper and growth was faster. The WIP inventory build to $401M (+82% QoQ) deserves monitoring, and the bear is correct that any Q3 guidance miss would crack the narrative quickly. The concern about hyperscaler capex deceleration is real and not to be dismissed.
Continues in the full debate transcript — unlock Pro ($39/mo or $379/yr) →
Stress-test your own thesis on MPWR (or any US stock)
Enter a ticker, your optional thesis, and your email. Twelve AI agents will argue the bull and bear case, test your reasoning, and email your 4-page PDF report.
Unlock the full trade plan & Trader desk
Stop loss and take profit levels, position sizing, the risk team's debate and the full transcript for MPWR are in Pro ($39/mo or $379/yr, 5/day). Or upgrade to Trader ($99/mo or $949/yr, 10/day) for live position tracking vs the S&P 500, price/stop email alerts, weekly Monday AI thesis re-checks, and an Alpaca paper-trading order ticket.
Get Pro — $39/mo →Get Trader — $99/mo →5-Report Pack — $19 one-time →Founding Lifetime Pass — $499 (20 seats) →Other recent analyses
This page was generated automatically by HedgePick's AI agents from public market data. It is general information, not personalized investment advice, and not a recommendation to buy or sell any security. AI output can be wrong or out of date. HedgePick is not a registered investment adviser or broker-dealer. Do your own research and consider your own situation before trading.